Group 1 - The Hong Kong Innovative Drug ETF Penghua (159286) experienced a decline of 4.01% on October 14, with a trading volume of 89.768 million yuan [1] - The fund's shares increased by 18 million to a total of 587 million shares, with a net asset value of 530 million yuan [1] - Over the past 20 trading days, the fund's shares have increased by 42 million [1] Group 2 - The performance benchmark for the Hong Kong Innovative Drug ETF Penghua is the National Index of Hong Kong Stock Connect Innovative Drugs, adjusted for exchange rates [1] - The fund has been managed by Penghua Fund Management Co., Ltd., with managers Lin Song and Zhang Yuxiang [1] - Since its establishment on August 20, 2025, the fund has reported a return of -9.69%, with a one-month return of -10.57% [1]
10月14日港股创新药ETF鹏华（159286）份额增加1800.00万份，最新份额5.87亿份，最新规模5.30亿元
Xin Lang Cai Jing·2025-10-15 03:23